Showing results (21-30 of 37) with videos related to
Sort By:
Pageof 4
Experimental and Therapeutic Medicine|October 12, 2019
High mobility group box protein 1 neutralization therapy in ovine bacteremia: Lessons learned from an ovine septic shock model incorporating intensive care supportNatalie E Stevens, Coralie H Nash, Cara K Fraser, et al.Critical Care Medicine|March 11, 2016
Triiodothyronine Administration in a Model of Septic Shock: A Randomized Blinded Placebo-Controlled TrialMatthew J Maiden, Marianne J Chapman, David J Torpy, et al.Experimental and Therapeutic Medicine|June 28, 2024
Triiodothyronine supplementation in a sheep model of intensive careMatthew J Maiden, David J Torpy, Guy L Ludbrook, et al.American Journal of Respiratory and Critical Care Medicine|March 12, 2016
Structure and Function of the Kidney in Septic Shock. A Prospective Controlled Experimental StudyMatthew J Maiden, Sophia Otto, John K Brealey, et al.Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|December 4, 2023
Study protocol and statistical analysis plan for the 20% Human Albumin Solution Fluid Bolus Administration Therapy in Patients after Cardiac Surgery-ll (HAS FLAIR-II) trialGeoffrey Wigmore, Adam M Deane, James Anstey, et al.Australian Critical Care : Official Journal of the Confederation of Australian Critical Care Nurses|May 18, 2026
Communication between intensive care unit doctors and general practitioners: A sequential multiphase project to increase prevalence of communicationShakeel Manuel, Sophie A Witherspoon, Lewis Hackenberger, et al.Australian Critical Care : Official Journal of the Confederation of Australian Critical Care Nurses|November 26, 2025
Clinical practice guideline for nonpharmacological prevention and management of patient agitation in the adult intensive care unit (CALM ICU)Anne Mette N Adams, Diane Chamberlain, Matthew J Maiden, et al.Journal of Cardiothoracic and Vascular Anesthesia|January 21, 2025
The Renal Effect of 20% Human Albumin Solution Fluid Bolus Therapy in Patients After Cardiac Surgery. A Secondary Analysis of the HAS FLAIR II Randomized Clinical TrialGeoffrey J Wigmore, Adam M Deane, Jeffrey J Presneill, et al.Intensive Care Medicine|July 2, 2024
Twenty percent human albumin solution fluid bolus administration therapy in patients after cardiac surgery-II: a multicentre randomised controlled trialGeoffrey J Wigmore, Adam M Deane, Jeffrey J Presneill, et al.Australian Health Review : a Publication of the Australian Hospital Association|November 24, 2025
Critical care survivors' reported satisfaction with experience of their general practitioner and general practice clinic: a multi-centre observational cohort studyNina Leggett, Yuhao Wang, Sarah Burleigh, et al.Pageof 4